UBE2C Antikörper (full length)
Kurzübersicht für UBE2C Antikörper (full length) (ABIN7879293)
Target
Alle UBE2C Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Bindungsspezifität
- full length
-
Verwendungszweck
- UBE2C Antibody / UBCH10 (azide and preservative free)
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- Recombinant human full-length protein was used as the immunogen for the UBE2C antibody.
-
Isotyp
- IgG2b, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the UBE2C antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Konservierungsmittel
- Azide free
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store the UBE2C antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- UBE2C (Ubiquitin-Conjugating Enzyme E2C (UBE2C))
-
Andere Bezeichnung
- UBE2C
-
Hintergrund
- The ubiquitin (Ub) pathway involves three sequential enzymatic steps that facilitate the conjugation of Ub and Ub-like molecules to specific protein substrates. The first step requires the ATP-dependent activation of the Ub C-terminus and the assembly of multi-Ub chains by the Ub-activating enzyme known as the E1 component. The Ub chain is then conjugated to the Ubconjugating enzyme (E2) to generate an intermediate Ub-E2 complex. The Ub-ligase (E3) then catalyzes the transfer of Ub from E2 to the appropriate protein substrate. UBE2C, also designated UBCH10 in human, is an E2 ubiquitin conjugating enzyme for the anaphase promoting complex (APC), which coordinates mitosis and G1 by sequentially promoting the degradation of key cell-cycle regulators. UBE2C is overexpressed in many different types of cancers and may be a potential therapeutic target.
-
UniProt
- O00762
-
Pathways
- Ubiquitin Proteasome Pathway
Target
-